Will the warrant amendments trigger any acceleration or conversion events that could influence short‑term supply and demand dynamics?

Short‑term impact: The filing indicates that IM Cannabis has renegotiated the terms of its outstanding common‑share purchase warrants. While the release does not spell out the exact language, any amendment that broadens the conversion price, shortens the exercise window, or adds “automatic‑conversion” or “acceleration” clauses creates a clear trigger for warrant holders to convert or exercise en masse once the stock trades at or above the new strike. In practice, that means a potential surge of newly‑issued shares hitting the market within weeks of the amendment’s effectiveness—raising short‑term supply and putting downward pressure on the stock, especially if a sizable portion of the warrant pool is held by institutional investors who are likely to liquidate quickly.

Trading take‑away: Until the specific amendment language is disclosed (or the Form F‑3 resale registration is reviewed), the safest bias is neutral‑to‑bear on the near‑term. Anticipate a modest‑to‑moderate increase in float and watch for a spike in pre‑announcement trading volume as holders position ahead of a possible conversion window. If the price holds above the revised exercise price, expect a sell‑side‑bias as warrants are likely to be exercised; a break below that level reduces conversion pressure and may support a short‑cover rally. Set a watch‑list for the warrant conversion date, tighten stops around the current support level, and consider a short‑position or a protective put if the stock is already trading near the new strike price.